Treatment modalities for primary basal cell carcinomas
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Treatment Modalities for Primary Basal Cell Carcinomas." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452324/all/Treatment_modalities_for_primary_basal_cell_carcinomas.
Treatment modalities for primary basal cell carcinomas. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452324/all/Treatment_modalities_for_primary_basal_cell_carcinomas. Accessed October 15, 2019.
Treatment modalities for primary basal cell carcinomas. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/452324/all/Treatment_modalities_for_primary_basal_cell_carcinomas
Treatment Modalities for Primary Basal Cell Carcinomas [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452324/all/Treatment_modalities_for_primary_basal_cell_carcinomas.
TY - ELEC
T1 - Treatment modalities for primary basal cell carcinomas
ID - 452324
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452324/all/Treatment_modalities_for_primary_basal_cell_carcinomas
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine